Dr Janith Seneviratne
Honorary (Fellow)
The Sir Peter MacCallum Department of Oncology
17 Scholarly works
0 Projects
HIGHLIGHTS
2026
Journal article
Embryonic stem cell factors DPPA2/4 amplify active H3K4me3–H2AK119ub chromatin domains in non-small cell lung cancer
DOI: 10.1101/gad.353102.1252025
Journal article
Trajectory analysis reveals an uncommitted neuroblastic state in MYCN-driven neuroblastoma development
DOI: 10.1093/neuonc/noaf1292025
Journal article
The Super Enhancer-Driven Long Noncoding RNA PRKCQ-AS1 Promotes Neuroblastoma Tumorigenesis by Interacting With MSI2 Protein and Is Targetable by Small Molecule Compounds
DOI: 10.1002/advs.2024125202024
Journal article
Combined inhibition of histone methyltransferases EZH2 and DOT1L is an effective therapy for neuroblastoma
DOI: 10.1002/cam4.700822024
Journal article
Golgi-localized Ring Finger Protein 121 is necessary for MYCN-driven neuroblastoma tumorigenesis
DOI: 10.1038/s42003-024-06899-82024
Journal article
Loss of the stress sensor GADD45A promotes stem cell activity and ferroptosis resistance in LGR4/HOXA9-dependent AML
DOI: 10.1182/blood.20240240722024
Journal article
A low-input high resolution sequential chromatin immunoprecipitation method captures genome-wide dynamics of bivalent chromatin
DOI: 10.1186/s13072-024-00527-9
RECENT SCHOLARLY WORKS
2024
Journal article
MYCN and SNRPD3 cooperate to maintain a balance of alternative splicing events that drives neuroblastoma progression
DOI: 10.1038/s41388-023-02897-y2023
Journal article
Mitotic Dysregulation at Tumor Initiation Creates a Therapeutic Vulnerability to Combination Anti-Mitotic and Pro-Apoptotic Agents for MYCN-Driven Neuroblastoma
DOI: 10.3390/ijms2421155712023
Journal article
Inhibition of mitochondrial translocase SLC25A5 and histone deacetylation is an effective combination therapy in neuroblastoma
DOI: 10.1002/ijc.34349